Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Medical Imaging
  4. Volume 20, Issue 1
  5. Article
Volume 20, Issue 1
  • ISSN: 1573-4056
  • E-ISSN: 1875-6603
file format pdf download PDF
side by side viewer icon HTML

Abstract

Objective

This study is to explore the efficacy of contrast-enhanced ultrasound (CEUS) / Gd-EOB-DTPA-enhanced magnetic resonance imaging (MRI) fusion imaging-guided(fusion group)radiofrequency ablation (RFA) conventional ultrasound imaging-guided (conventional group) RFA for colorectal cancer liver metastases (CRLM) in a short-term.

Methods

From December 2020 to December 2021, patients who underwent imaging-guided RFA of CRLM at our hospital with available CT/MRI images were enrolled consecutively. 22 patients with 46 lesions had undergone conventional group RFA whereas 29 patients with 63 lesions had undergone fusion group RFA. The lesion detection rate, technical success, local tumor progression (LTP) and complications were calculated.

Results

In this retrospective study, 51 patients with 130 lesions were diagnosed with CRLM. However, there were 12 lesions and 9 lesions invisible in the conventional group and fusion group, respectively. The lesion detection rate on the fusion imaging was significantly higher than on the US or CEUS in the fusion group (<0.05). There were no significant differences of the detection rate between the conventional group and the fusion group (=0.207). In both groups, the technical success rate was 100%. For local tumor progression (LTP), there were no significant differences between the two groups (>0.05). The complications after ablation had no significant differences between the two groups (=0.97).

Conclusion

CEUS/ Gd-EOB-DTPA-enhanced MRI fusion imaging is a safe and effective method for RFA in the management of CRLM patients, and it may improve the therapeutic effect by detecting small lesions early.

© 2024 The Author(s). Published by Bentham Science Publisher.
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/cmir/10.2174/1573405620666230405100839
2024-01-01
2024-10-15

  • From This Site

    /content/journals/cmir/10.2174/1573405620666230405100839
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/cmir/20/1/CMIM-20-e050423215454.html?itemId=/content/journals/cmir/10.2174/1573405620666230405100839&mimeType=html&fmt=ahah

References

  1. FerlayJ. SoerjomataramI. DikshitR. EserS. MathersC. RebeloM. ParkinD.M. FormanD. BrayF. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012.Int. J. Cancer20151365E359E38610.1002/ijc.2921025220842
     [Google Scholar]
  2. BrayF. FerlayJ. SoerjomataramI. SiegelR.L. TorreL.A. JemalA. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J. Clin.201868639442410.3322/caac.2149230207593
     [Google Scholar]
  3. ZarourL.R. AnandS. BillingsleyK.G. BissonW.H. CercekA. ClarkeM.F. CoussensL.M. GastC.E. GeltzeilerC.B. HansenL. KelleyK.A. LopezC.D. RanaS.R. RuhlR. TsikitisV.L. VaccaroG.M. WongM.H. MayoS.C. Colorectal cancer liver metastasis: Evolving paradigms and future directions.Cell. Mol. Gastroenterol. Hepatol.20173216317310.1016/j.jcmgh.2017.01.00628275683
     [Google Scholar]
  4. AbdallaE.K. VautheyJ.N. EllisL.M. EllisV. PollockR. BroglioK.R. HessK. CurleyS.A. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases.Ann. Surg.2004239681882710.1097/01.sla.0000128305.90650.7115166961
     [Google Scholar]
  5. WongS.L. ManguP.B. ChotiM.A. CrocenziT.S. DoddG.D.III DorfmanG.S. EngC. FongY. GiustiA.F. LuD. MarslandT.A. MichelsonR. PostonG.J. SchragD. SeidenfeldJ. BensonA.B.III American society of clinical oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer.J. Clin. Oncol.201028349350810.1200/JCO.2009.23.445019841322
     [Google Scholar]
  6. BensonA.B. VenookA.P. Al-HawaryM.M. ArainM.A. ChenY.J. CiomborK.K. CohenS. CooperH.S. DemingD. FarkasL. Garrido-LagunaI. GremJ.L. GunnA. HechtJ.R. HoffeS. HubbardJ. HuntS. JohungK.L. KirilcukN. KrishnamurthiS. MessersmithW.A. MeyerhardtJ. MillerE.D. MulcahyM.F. NurkinS. OvermanM.J. ParikhA. PatelH. PedersenK. SaltzL. SchneiderC. ShibataD. SkibberJ.M. SofocleousC.T. StoffelE.M. Stotsky-HimelfarbE. WillettC.G. GregoryK.M. GurskiL.A. Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology.J. Natl. Compr. Canc. Netw.202119332935910.6004/jnccn.2021.001233724754
     [Google Scholar]
  7. AhmedM. SolbiatiL. BraceC.L. BreenD.J. CallstromM.R. CharboneauJ.W. ChenM.H. ChoiB.I. de BaèreT. DoddG.D.III DupuyD.E. GervaisD.A. GianfeliceD. GillamsA.R. LeeF.T.Jr LeenE. LencioniR. LittrupP.J. LivraghiT. LuD.S. McGahanJ.P. MeloniM.F. NikolicB. PereiraP.L. LiangP. RhimH. RoseS.C. SalemR. SofocleousC.T. SolomonS.B. SoulenM.C. TanakaM. VoglT.J. WoodB.J. GoldbergS.N. Image-guided tumor ablation: Standardization of terminology and reporting criteria--a 10-year update.Radiology2014273124126010.1148/radiol.1413295824927329
     [Google Scholar]
  8. KonopkeR. BunkA. KerstingS. The role of contrast-enhanced ultrasound for focal liver lesion detection: an overview.Ultrasound Med. Biol.200733101515152610.1016/j.ultrasmedbio.2007.04.00917618038
     [Google Scholar]
  9. UsmanS. SmithL. BrownN. MajorV. Diagnostic accuracy of Magnetic Resonance Imaging using liver tissue specific contrast agents and contrast enhanced Multi Detector Computed Tomography: A systematic review of diagnostic test in Hepatocellular Carcinoma (HCC).Radiography2018244e109e11410.1016/j.radi.2018.05.00230292515
     [Google Scholar]
  10. LiX.Q. WangX. ZhaoD.W. SunJ. LiuJ.J. LinD.D. YangG. LiuH. XiaZ.Y. JiaC.Y. LiH.J. Application of Gd-EOB-DTPA-enhanced magnetic resonance imaging (MRI) in hepatocellular carcinoma.World J. Surg. Oncol.202018121910.1186/s12957‑020‑01996‑432828123
     [Google Scholar]
  11. KimY.K. LeeY.H. KwakH.S. KimC.S. HanY.M. Detection of liver metastases: Gadoxetic acid-enhanced three-dimensional MR imaging versus ferucarbotran-enhanced MR imaging.Eur. J. Radiol.201073113113610.1016/j.ejrad.2008.09.02718996659
     [Google Scholar]
  12. KogitaS. ImaiY. OkadaM. KimT. OnishiH. TakamuraM. FukudaK. IguraT. SawaiY. MorimotoO. HoriM. NaganoH. WakasaK. HayashiN. MurakamiT. Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: Correlation with histological grading and portal blood flow.Eur. Radiol.201020102405241310.1007/s00330‑010‑1812‑920490505
     [Google Scholar]
  13. Berger-KulemannV. SchimaW. BaroudS. KoelblingerC. KaczirekK. GruenbergerT. SchindlM. MareschJ. WeberM. Ba-SsalamahA. Gadoxetic acid-enhanced 3.0 T MR imaging versus multidetector-row CT in the detection of colorectal metastases in fatty liver using intraoperative ultrasound and histopathology as a standard of reference.Eur. J. Surg. Oncol.201238867067610.1016/j.ejso.2012.05.00422652037
     [Google Scholar]
  14. ChenL. ZhangJ. ZhangL. BaoJ. LiuC. XiaY. HuangX. WangJ. Meta-analysis of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging for the detection of liver metastases.PLoS One2012711e4868110.1371/journal.pone.004868123144927
     [Google Scholar]
  15. VreugdenburgT.D. MaN. DuncanJ.K. RiitanoD. CameronA.L. MaddernG.J. Comparative diagnostic accuracy of hepatocyte-specific gadoxetic acid (Gd-EOB-DTPA) enhanced MR imaging and contrast enhanced CT for the detection of liver metastases: A systematic review and meta-analysis.Int. J. Colorectal Dis.201631111739174910.1007/s00384‑016‑2664‑927682648
     [Google Scholar]
  16. ClevertD.A. PaprottkaP.M. HelckA. ReiserM. TrummC.G. Image fusion in the management of thermal tumor ablation of the liver.Clin. Hemorheol. Microcirc.2012522-420521610.3233/CH‑2012‑159822960300
     [Google Scholar]
  17. MakinoY. ImaiY. IguraT. OhamaH. KogitaS. SawaiY. FukudaK. OhashiH. MurakamiT. Usefulness of the multimodality fusion imaging for the diagnosis and treatment of hepatocellular carcinoma.Dig. Dis.201230658058710.1159/00034307023258098
     [Google Scholar]
  18. Zhong-ZhenS. KaiL. Rong-QinZ. Er-JiaoX. TingZ. Ao-HuaZ. Shu-FangY. Xu-QiH. A feasibility study for determining ablative margin with 3D-CEUS-CT/MR image fusion after radiofrequency ablation of hepatocellular carcinoma.Ultraschall Med.2012337E250E25510.1055/s‑0032‑132546623238803
     [Google Scholar]
  19. LvS. LongY. SuZ. ZhengR. LiK. ZhouH. QiuC. YinT. XuE. Investigating the accuracy of ultrasound-ultrasound fusion imaging for evaluating the ablation effect via special phantom-simulated liver tumors.Ultrasound Med. Biol.201945113067307410.1016/j.ultrasmedbio.2019.07.41531447240
     [Google Scholar]
  20. MurakamiT. SofueK. HoriM. Diagnosis of hepatocellular carcinoma using Gd-EOB-DTPA MR imaging.Magn. Reson. Med. Sci.202221116818110.2463/mrms.rev.2021‑003134421091
     [Google Scholar]
  21. EwertsenC. SăftoiuA. GruionuL.G. KarstrupS. NielsenM.B. Real-time image fusion involving diagnostic ultrasound.AJR Am. J. Roentgenol.20132003W249W25510.2214/AJR.12.890423436869
     [Google Scholar]
  22. LaimerG. SchullianP. JaschkeN. PutzerD. EberleG. AlzagaA. OdisioB. BaleR. Minimal ablative margin (MAM) assessment with image fusion: An independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation.Eur. Radiol.20203052463247210.1007/s00330‑019‑06609‑732002642
     [Google Scholar]
  23. SacksD. McClennyT.E. JohnF.C. CurtisA.L. Society of interventional radiology clinical practice guidelines.J. Vasc. Interv. Radiol.2003149 Pt 2S199S20210.1097/01.RVI.0000094584.83406.3e
     [Google Scholar]
  24. ZorziD. MullenJ. AbdallaE. PawlikT. AndresA. MuratoreA. CurleyS. MenthaG. CapussottiL. VautheyJ. Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases.J. Gastrointest. Surg.2006101869410.1016/j.gassur.2005.07.02216368496
     [Google Scholar]
  25. GillamsA. GoldbergN. AhmedM. BaleR. BreenD. CallstromM. ChenM.H. ChoiB.I. de BaereT. DupuyD. GangiA. GervaisD. HelmbergerT. JungE.M. LeeF. LencioniR. LiangP. LivraghiT. LuD. MeloniF. PereiraP. PiscagliaF. RhimH. SalemR. SofocleousC. SolomonS.B. SoulenM. TanakaM. VoglT. WoodB. SolbiatiL. Thermal ablation of colorectal liver metastases: A position paper by an international panel of ablation experts, the interventional oncology sans frontières meeting 2013.Eur. Radiol.201525123438345410.1007/s00330‑015‑3779‑z25994193
     [Google Scholar]
  26. FowlerK.J. LinehanD.C. MeniasC.O. Colorectal liver metastases: State of the art imaging.Ann. Surg. Oncol.20132041185119310.1245/s10434‑012‑2730‑723115006
     [Google Scholar]
  27. MaceraA. LarioC. PetracchiniM. GalloT. ReggeD. FlorianiI. RiberoD. CapussottiL. CirilloS. Staging of colorectal liver metastases after preoperative chemotherapy. Diffusion-weighted imaging in combination with Gd-EOB-DTPA MRI sequences increases sensitivity and diagnostic accuracy.Eur. Radiol.201323373974710.1007/s00330‑012‑2658‑022976920
     [Google Scholar]
  28. PageA.J. CosgroveD.C. HermanJ.M. PawlikT.M. Advances in understanding of colorectal liver metastasis and implications for the clinic.Expert Rev. Gastroenterol. Hepatol.20159224525910.1586/17474124.2014.94089725033964
     [Google Scholar]
  29. HirookaM. IuchiH. KumagiT. ShigematsuS. HiraokaA. UeharaT. KuroseK. HoriikeN. OnjiM. Virtual sonographic radiofrequency ablation of hepatocellular carcinoma visualized on CT but not on conventional sonography.AJR Am. J. Roentgenol.2006186S5tS255S26010.2214/AJR.04.125216632685
     [Google Scholar]
  30. KunishiY. NumataK. MorimotoM. OkadaM. KanekoT. MaedaS. TanakaK. Efficacy of fusion imaging combining sonography and hepatobiliary phase MRI with Gd-EOB-DTPA to detect small hepatocellular carcinoma.AJR Am. J. Roentgenol.2012198110611410.2214/AJR.10.603922194485
     [Google Scholar]
  31. LaimerG. JaschkeN. SchullianP. PutzerD. EberleG. SolbiatiM. SolbiatiL. GoldbergS.N. BaleR. Volumetric assessment of the periablational safety margin after thermal ablation of colorectal liver metastases.Eur. Radiol.20213196489649910.1007/s00330‑020‑07579‑x33447860
     [Google Scholar]
  32. WangX. SofocleousC.T. ErinjeriJ.P. PetreE.N. GonenM. DoK.G. BrownK.T. CoveyA.M. BrodyL.A. AlagoW. ThorntonR.H. KemenyN.E. SolomonS.B. Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases.Cardiovasc. Intervent. Radiol.201336116617510.1007/s00270‑012‑0377‑122535243
     [Google Scholar]
  33. NakazawaT. KokubuS. ShibuyaA. OnoK. WatanabeM. HidakaH. TsuchihashiT. SaigenjiK. Radiofrequency ablation of hepatocellular carcinoma: Correlation between local tumor progression after ablation and ablative margin.AJR Am. J. Roentgenol.2007188248048810.2214/AJR.05.207917242258
     [Google Scholar]
  34. KomatsuS. MurakamiM. FukumotoT. HoriY. HishikawaY. KuY. Risk factors for survival and local recurrence after particle radiotherapy for single small hepatocellular carcinoma.Br. J. Surg.201198455856410.1002/bjs.739721246516
     [Google Scholar]
  35. HaoY. NumataK. IshiiT. FukudaH. MaedaS. NakanoM. TanakaK. Rate of local tumor progression following radiofrequency ablation of pathologically early hepatocellular carcinoma.World J. Gastroenterol.201723173111312110.3748/wjg.v23.i17.311128533668
     [Google Scholar]
  36. JuJ.X. ZengQ.J. XuE.J. HeX.Q. TanL. HuangQ.N. LiK. ZhengR.Q. Intraprocedural contrast-enhanced ultrasound-CT/MR fusion imaging assessment in HCC thermal ablation to reduce local tumor progression: Compared with routine contrast-enhanced ultrasound.Int. J. Hyperthermia201936178479210.1080/02656736.2019.164089931431086
     [Google Scholar]
/content/journals/cmir/10.2174/1573405620666230405100839
Loading
The Short-term Efficacy of Contrast-enhanced Ultrasound (CEUS) and Gd-EOB-DTPA-enhanced Magnetic Resonance Imaging (MRI) Fusion Imaging-guided Radiofrequency Ablation (RFA) for Colorectal Liver Metastasis (CRLM)
Curr. Med. Imaging 20, E050423215454 (2024); https://doi.org/10.2174/1573405620666230405100839
/content/journals/cmir/10.2174/1573405620666230405100839
/content/journals/cmir/10.2174/1573405620666230405100839
Loading

Data & Media loading...

  • Article Type: Research Article
Keyword(s): Ablation; CEUS; Colorectal liver metastases; Fusion imaging; Local tumor progression; Radiofrequency

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test